BARDA Medical Countermeasures (MCMs) for Influenza and Emerging Diseases
IDIQ
Overview
Ceiling
$13,399,072,878
Primary Sponsoring Agency
Who Can Use
One Agency
Primary PSC
Primary Set Aside
None
Extent Competed
Full And Open Competition
BARDA Medical Countermeasures (MCMs) for Influenza and Emerging Diseases awarded by HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) in February 2022 accepts orders through February 2027.
The IDIQ has a reported ceiling of $13,399,072,878, and as of today, $197,996,725 has been obligated through the vehicle
with a total reported backlog of $527,412,004.
The IDIQ was awarded
full & open and has a primary NAICS code of 325414.
Status
Period of Performance
2/22/22
Start Date
2/21/27
Ordering Period End Date
Task Order Obligations and Backlog
$198.0M
Total Obligated
$198.0M
Current Award
$725.4M
Potential Award
$0.0
Funded Backlog
$527.4M
Total Backlog
Vehicle Award Share
Contractors with greatest percentage of obligations for BARDA Medical Countermeasures (MCMs) for Influenza and Emerging Diseases
Vehicle Award Share
Federal Award Analysis
BARDA Medical Countermeasures (MCMs) for Influenza and Emerging Diseases contract spending
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Awardees
BARDA Medical Countermeasures (MCMs) for Influenza and Emerging Diseases awardees
Contract Awards
BARDA Medical Countermeasures (MCMs) for Influenza and Emerging Diseases task orders
Subcontract Awards